Silvergate Pharmaceuticals Receives Approval for Epaned

Silvergate Pharmaceuticals Inc. announced that the United States Food and Drug Administration approved Epaned™ (enalapril maleate Powder for Oral Solution), for the treatment of hypertension in people one month and older.

As quoted in the press release:

Epaned enables accurate dosing for children who until now have relied on an adjusted adult dose. Epaned is available through an extensive network of pharmacies and a qualified mail order service. Epaned will be reimbursed by most private insurance plans and state Medicaid programs.

Click here to read the Silvergate Pharmaceuticals Inc. press release